Cancer statistics for <scp>A</scp> merican <scp>I</scp> ndian and <scp>A</scp> laska <scp>N</scp> ative individuals, 2022: Including increasing disparities in early onset colorectal cancer
2022/11/08 by Tyler B. Kratzer, Ahmedin Jemal, Kimberly D. Miller +8 · 28 citations
Medicine · #Colorectal Cancer Screening and Detection #Global Cancer Incidence and Screening #Cancer Risks and Factors
paper · pdf · doi:10.3322/caac.21757
Abstract
American Indian and Alaska Native (AIAN) individuals are diverse culturally and geographically but share a high prevalence of chronic illness, largely because of obstacles to high-quality health care. The authors comprehensively examined cancer incidence and mortality among non-Hispanic AIAN individuals, compared with non-Hispanic White individuals for context, using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Overall cancer rates among AIAN individuals were 2% higher than among White individuals for incidence (2014 through 2018, confined to Purchased/Referred Care Delivery Area counties to reduce racial misclassification) but 18% higher for mortality (2015 through 2019). However, disparities varied widely by cancer type and geographic region. For example, breast and prostate cancer mortality rates are 8% and 31% higher, respectively, in AIAN individuals than in White individuals despite lower incidence and the availability of early detection tests for these cancers. The burden among AIAN individuals is highest for infection-related cancers (liver, stomach, and cervix), for kidney cancer, and for colorectal cancer among indigenous Alaskans (91.3 vs. 35.5 cases per 100,000 for White Alaskans), who have the highest rates in the world. Steep increases for early onset colorectal cancer, from 18.8 cases per 100,000 Native Alaskans aged 20-49 years during 1998 through 2002 to 34.8 cases per 100,000 during 2014 through 2018, exacerbated this disparity. Death rates for infection-related cancers (liver, stomach, and cervix), as well as kidney cancer, were approximately two-fold higher among AIAN individuals compared with White individuals. These findings highlight the need for more effective strategies to reduce the prevalence of chronic oncogenic infections and improve access to high-quality cancer screening and treatment for AIAN individuals. Mitigating the disparate burden will require expanded financial support of tribal health care as well as increased collaboration and engagement with this marginalized population.
Citations
Cited by
- Prostate cancer statistics, 2025
- Colorectal cancer statistics, 2026
- American Cancer Society’s Report on the Status of Cancer Disparities in the United States, 2025
- Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions. [europepmc]
- Indigenizing and Ruralizing NCI Screen to Save Program: Resources, Optimizing Outreach, Teaching, Science (ROOTS). [europepmc]
- A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits. [europepmc]
- Cordycepin remodels the tumor microenvironment of colorectal cancer by down-regulating the expression of PD-L1. [europepmc]
- Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage. [europepmc]
- Comparison of Capture Rates of the National Cancer Database Across Race and Ethnicity. [europepmc]
- Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures. [europepmc]
- Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer. [europepmc]
- The Chickahominy T.R.U.T.H. (Trust, Research, Understand, Teach, and Heal) Project-A Tribal Community-Academic Partnership for Understanding the Impact of Structural Factors on Perceived Cancer Risk in Rural Virginia. [europepmc]
- Characterizing Cancer Burden in the American Indian Population in North Carolina. [europepmc]
- New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model. [europepmc]
- MAP7 drives EMT and cisplatin resistance in ovarian cancer via wnt/β-catenin signaling. [europepmc]
- Multiple myeloma incidence and mortality trends in the United States, 1999-2020. [europepmc]
- Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer. [europepmc]
- Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. [europepmc]
- Understanding determinants of lung cancer preventive care in at-risk urban American Indians and Alaska Natives: A mixed-methods study. [europepmc]
- Trends and Symptoms Among Increasing Proportion of African Americans with Early-Onset Colorectal Cancer over a 60-Year Period. [europepmc]
- Where Should the Cancer Control Interventions Target: A Geospatial Hotspot Analysis for Major Cancer Mortality 2018 to 2022 in the United States. [europepmc]
- Using Community-Based Participatory Research Approaches to Inform Development of Culturally Appropriate Cancer Informational Materials for the Pueblo of Zuni. [europepmc]
- Barriers and unmet needs related to healthcare for American Indian and Alaska Native communities: improving access to specialty care and clinical trials. [europepmc]
- Understanding and Addressing Cancer Disparities Among American Indians in North Carolina: The Southeastern American Indian Cancer Health Equity Partnership (SAICEP). [europepmc]
- Prostate cancer statistics, 2025. [europepmc]
- Integrative multi-omics deciphers the potential mechanism and microbial biomarkers for lymph node metastasis in colorectal cancer. [europepmc]
- American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025. [europepmc]
- Colorectal cancer statistics, 2026. [europepmc]
Related